Shipoftheseus

ShipoftheseusShipoftheseus
S

Shipoftheseus

Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.

DR 02026Active
Rate

About

Ship of Theseus is a biotechnology company focused on developing biologics derived from the homeobox (HOX) family of transcription factors. They modify HOX proteins to overcome their natural rapid elimination in cells, enabling their use as pharmaceuticals for various therapeutic applications, including stem cell expansion and wound healing.
Frequently asked

What does Shipoftheseus do?

Ship of Theseus is a biotechnology company focused on developing biologics derived from the homeobox (HOX) family of transcription factors. They modify HOX proteins to overcome their natural rapid elimination in cells, enabling their use as pharmaceuticals for various therapeutic applications, including stem cell expansion and wound healing.

What is Shipoftheseus's Effective Domain Rating?

StartupHub's Effective Domain Rating for Shipoftheseus is 0 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is fairly rated against its Ahrefs Domain Rating of 0.

Is Shipoftheseus trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Shipoftheseus is 60 out of 100, based on site security posture and privacy practices.

When was Shipoftheseus founded?

Shipoftheseus was founded in 2026.

What industry does Shipoftheseus operate in?

Shipoftheseus operates in Biotech, Drug Discovery, Genomics, Cellular Therapy, Stem Cell Research, Biologics.

Comments

No comments yet. Be the first to share your take.